Provided herein are pharmaceutical agents useful for therapy and/or prophylaxis in a mammal, pharmaceutical composition comprising such compounds, and their use as menin/MLL protein/protein interaction inhibitors, useful for treating diseases such as cancer, including but not limited to leukemia, myelodysplastic syndrome (MDS), and myeloproliferative neoplasms (MPN); and diabetes.
本文提供了在哺乳动物中用于治疗和/或预防的药物剂,包括含有这些化合物的药物组合物,以及它们作为menin/MLL蛋白质相互作用
抑制剂的用途,用于治疗癌症等疾病,包括但不限于白血病、骨髓增生异常综合征(MDS)和骨髓增生性肿瘤(M
PN);以及糖尿病。